Clinical Trial Update: Vaginal Estriol in Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating vaginal estriol for multiple sclerosis and neurogenic bladder has results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Neurogenic Bladder

Drugs mentioned

• Vaginal Estriol (estriol)

Snippet

Sponsor: Texas Tech University Health Sciences Center | Conditions: Multiple Sclerosis, Neurogenic Bladder | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2022-09-21